CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated other comprehensive income (loss)	Total
Balance, beginning of period at Dec. 31, 2022	$ 2	$ 225,333	$ (166,748)	$ (6)	$ 58,581
Balance, beginning of period (in shares) at Dec. 31, 2022	38,288,188
Increase (Decrease) in Redeemable Convertible Preferred Stock and Stockholders' Equity [Roll Forward]
Exercise of stock options		58			58
Exercise of stock options (in shares)	88,756
Vesting of restricted stock units		(94)			(94)
Vesting of restricted stock units (in shares)	22,127
Net Income (Loss)			(18,802)		(18,802)
Other comprehensive income (loss)				6	6
Stock-based compensation		2,375			2,375
Balance, end of period at Mar. 31, 2023	$ 2	227,672	(185,550)		42,124
Balance, end of period (in shares) at Mar. 31, 2023	38,399,071
Balance, beginning of period at Dec. 31, 2022	$ 2	225,333	(166,748)	(6)	58,581
Balance, beginning of period (in shares) at Dec. 31, 2022	38,288,188
Increase (Decrease) in Redeemable Convertible Preferred Stock and Stockholders' Equity [Roll Forward]
Net Income (Loss)					(39,605)
Other comprehensive income (loss)					6
Balance, end of period at Jun. 30, 2023	$ 2	278,252	(206,353)		71,901
Balance, end of period (in shares) at Jun. 30, 2023	48,821,941
Balance, beginning of period at Mar. 31, 2023	$ 2	227,672	(185,550)		42,124
Balance, beginning of period (in shares) at Mar. 31, 2023	38,399,071
Increase (Decrease) in Redeemable Convertible Preferred Stock and Stockholders' Equity [Roll Forward]
Exercise of stock options		143			143
Exercise of stock options (in shares)	379,418
Vesting of restricted stock units (in shares)	(38,452)
Sale of common stock in underwritten offering, net of costs		47,817			47,817
Sale of common stock in underwritten offering, net of costs (in shares)	10,005,000
Net Income (Loss)			(20,803)		(20,803)
Stock-based compensation		2,620			2,620
Balance, end of period at Jun. 30, 2023	$ 2	278,252	(206,353)		71,901
Balance, end of period (in shares) at Jun. 30, 2023	48,821,941
Balance, beginning of period at Dec. 31, 2023	$ 2	283,839	(230,071)		53,770
Balance, beginning of period (in shares) at Dec. 31, 2023	49,117,738
Increase (Decrease) in Redeemable Convertible Preferred Stock and Stockholders' Equity [Roll Forward]
Exercise of stock options		36			36
Exercise of stock options (in shares)	65,482
Vesting of restricted stock units		(149)			(149)
Vesting of restricted stock units (in shares)	157,197
Net Income (Loss)			(23,484)		(23,484)
Other comprehensive income (loss)				(16)	(16)
Stock-based compensation		2,566			2,566
Balance, end of period at Mar. 31, 2024	$ 2	286,292	(253,555)	(16)	32,723
Balance, end of period (in shares) at Mar. 31, 2024	49,340,417
Balance, beginning of period at Dec. 31, 2023	$ 2	283,839	(230,071)		53,770
Balance, beginning of period (in shares) at Dec. 31, 2023	49,117,738
Increase (Decrease) in Redeemable Convertible Preferred Stock and Stockholders' Equity [Roll Forward]
Net Income (Loss)					(36,633)
Other comprehensive income (loss)					(12)
Balance, end of period at Jun. 30, 2024	$ 2	288,963	(266,704)	(12)	22,249
Balance, end of period (in shares) at Jun. 30, 2024	49,467,363
Balance, beginning of period at Mar. 31, 2024	$ 2	286,292	(253,555)	(16)	32,723
Balance, beginning of period (in shares) at Mar. 31, 2024	49,340,417
Increase (Decrease) in Redeemable Convertible Preferred Stock and Stockholders' Equity [Roll Forward]
Exercise of stock options		23			23
Exercise of stock options (in shares)	59,129
Vesting of restricted stock units		(65)			(65)
Vesting of restricted stock units (in shares)	67,817
Net Income (Loss)			(13,149)		(13,149)
Other comprehensive income (loss)				4	4
Stock-based compensation		2,713			2,713
Balance, end of period at Jun. 30, 2024	$ 2	$ 288,963	$ (266,704)	$ (12)	$ 22,249
Balance, end of period (in shares) at Jun. 30, 2024	49,467,363